Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 36% ± 14% | |
lung | 16 studies | 37% ± 14% | |
intestine | 13 studies | 36% ± 16% | |
kidney | 7 studies | 32% ± 8% | |
lymph node | 6 studies | 47% ± 14% | |
bone marrow | 5 studies | 31% ± 9% | |
eye | 5 studies | 25% ± 13% | |
uterus | 5 studies | 55% ± 18% | |
liver | 5 studies | 36% ± 16% | |
pancreas | 4 studies | 45% ± 15% | |
prostate | 4 studies | 24% ± 2% | |
breast | 4 studies | 41% ± 7% | |
adrenal gland | 3 studies | 42% ± 17% | |
esophagus | 3 studies | 33% ± 9% | |
brain | 3 studies | 27% ± 4% | |
skin | 3 studies | 35% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 17315.97 | 244 / 245 | 99% | 417.02 | 495 / 502 |
stomach | 100% | 28019.32 | 359 / 359 | 97% | 170.81 | 277 / 286 |
breast | 100% | 16159.54 | 457 / 459 | 96% | 371.96 | 1068 / 1118 |
bladder | 100% | 28359.67 | 21 / 21 | 94% | 272.38 | 473 / 504 |
intestine | 97% | 23481.60 | 939 / 966 | 96% | 163.59 | 506 / 527 |
lung | 98% | 14117.61 | 567 / 578 | 94% | 175.66 | 1083 / 1155 |
pancreas | 100% | 33069.71 | 327 / 328 | 92% | 164.96 | 164 / 178 |
thymus | 91% | 9469.59 | 597 / 653 | 100% | 425.91 | 602 / 605 |
ovary | 98% | 32382.27 | 177 / 180 | 89% | 140.51 | 384 / 430 |
kidney | 91% | 10542.48 | 81 / 89 | 89% | 139.20 | 800 / 901 |
uterus | 89% | 9790.70 | 151 / 170 | 90% | 163.14 | 411 / 459 |
esophagus | 91% | 17484.12 | 1311 / 1445 | 85% | 139.37 | 156 / 183 |
brain | 46% | 2976.91 | 1225 / 2642 | 99% | 223.71 | 700 / 705 |
adrenal gland | 63% | 8057.63 | 163 / 258 | 75% | 264.06 | 173 / 230 |
skin | 76% | 11121.79 | 1370 / 1809 | 42% | 39.56 | 196 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 385.18 | 29 / 29 |
spleen | 100% | 14466.78 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 236.20 | 1 / 1 |
adipose | 99% | 19625.99 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 24969.94 | 1321 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 159.75 | 43 / 45 |
muscle | 93% | 15065.50 | 743 / 803 | 0% | 0 | 0 / 0 |
heart | 90% | 17549.45 | 774 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 79% | 8562.19 | 734 / 929 | 0% | 0 | 0 / 0 |
liver | 3% | 116.05 | 6 / 226 | 29% | 28.40 | 117 / 406 |
eye | 0% | 0 | 0 / 0 | 11% | 6.44 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006281 | Biological process | DNA repair |
GO_0043434 | Biological process | response to peptide hormone |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0031175 | Biological process | neuron projection development |
GO_0060213 | Biological process | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
GO_0006974 | Biological process | DNA damage response |
GO_0021542 | Biological process | dentate gyrus development |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0008306 | Biological process | associative learning |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0021954 | Biological process | central nervous system neuron development |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0017148 | Biological process | negative regulation of translation |
GO_0007405 | Biological process | neuroblast proliferation |
GO_0007406 | Biological process | negative regulation of neuroblast proliferation |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005634 | Cellular component | nucleus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | BTG2 |
Protein name | Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3) |
Synonyms | PC3 |
Description | FUNCTION: Anti-proliferative protein; the function is mediated by association with deadenylase subunits of the CCR4-NOT complex. Activates mRNA deadenylation in a CNOT6 and CNOT7-dependent manner. In vitro can inhibit deadenylase activity of CNOT7 and CNOT8. Involved in cell cycle regulation. Could be involved in the growth arrest and differentiation of the neuronal precursors (By similarity). Modulates transcription regulation mediated by ESR1. Involved in mitochondrial depolarization and neurite outgrowth. . |
Accessions | ENST00000475157.1 P78543 ENST00000290551.5 |